As we observe World Heart Day, today, September 29, the ISN underscores the critical intersection of cardiovascular and kidney health through its Cardio-Kidney-Metabolic (CKM) Initiative. The ISN encourages healthcare professionals worldwide to integrate the CKM tools into their practice. By doing so, clinicians can refine their approach to treating patients with overlapping cardiovascular, kidney, and...
“Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community,” a new joint commentary led by the ISN and partnering organizations, has been published in Kidney International Reports®, the American Journal of Preventive Cardiology, and ESC Heart Failure. Read the full commentary Although essential for managing chronic kidney disease, heart...
Kidney International® Treatment of patients with IgA nephropathy: a call for a new paradigm Current treatments for IgA nephropathy (IgAN), including supportive care and corticosteroids, have limited success and significant side effects. Advances in understanding IgAN’s pathogenesis have led to new targeted therapies and a proposed dual approach: targeting IgAN-specific mechanisms (e.g., pathogenic IgA production) and managing...
Are you making the most of the latest clinical tools from the multi-society Cardio-Kidney-Metabolic (CKM) Initiative led by the ISN? The CKM Initiative addresses gaps in therapy, management, and implementation — supporting clinicians and advancing care for patients with CKM conditions. It includes an interactive CKM roadmap to guide the management of patients with cardio-kidney-metabolic...
The Optimization of SGLT2i Therapy Toolkit* is the latest educational offering from a multi-society cardio-kidney-metabolic initiative led by the ISN. This initiative offers resources for advancing the prevention and management of cardio-kidney-metabolic complications. The toolkit highlights the crucial role of SGLT2 inhibitors in improving outcomes for patients with both kidney and cardiovascular diseases. The SGLT2i...
The ISN has expanded its “Cardio-Kidney-Metabolic (CKM) Initiative” with the launch of a new interactive CKM roadmap designed to help clinicians manage patients with cardio-kidney-metabolic conditions and complications. Access the roadmap here Kidney, cardiovascular, and metabolic diseases are closely linked, contributing significantly to morbidity and mortality worldwide. Launched in 2022, the CKM initiative brings nephrologists and...
The toolkit on optimizing RAASi therapy and managing associated complications offers user-friendly infographics in Chinese, English, Spanish and Japanese. Access the Optimization of RAASi Therapy Toolkit here These visual aids serve as practical references for nephrologists, cardiologists, and other healthcare professionals caring for patients with heart and kidney conditions. The toolkit comprises five practical infographics, including...
Ensure you're well-equipped in the global effort to combat kidney diseases by exploring, utilizing and sharing these valuable ISN resources. CKD Early Identification & Intervention Toolkit To address the burden of chronic kidney disease (CKD) and its impact on global morbidity, the ISN and KDIGO collaborated on a series of tools for CKD early identification and...
